3-(4-Fluoro­phen­yl)-2-(2-naphth­yloxy)-4-oxo-5-phenyl-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile

The title compound, C(29)H(17)FN(4)O(2), may be used as a new precursor for obtaining bioactive mol­ecules. There are two crystallographically independent mol­ecules in the asymmetric unit. The phenyl ring, 4-fluoro­phenyl ring and 2-naphth­yloxy ring are twisted with respect to the pyrrolopyrimidin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jun-Kai, He, Mei, Hu, Yang-Gen
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2009
Materias:
Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970989/
https://www.ncbi.nlm.nih.gov/pubmed/21578245
http://dx.doi.org/10.1107/S1600536809039531
Descripción
Sumario:The title compound, C(29)H(17)FN(4)O(2), may be used as a new precursor for obtaining bioactive mol­ecules. There are two crystallographically independent mol­ecules in the asymmetric unit. The phenyl ring, 4-fluoro­phenyl ring and 2-naphth­yloxy ring are twisted with respect to the pyrrolopyrimidine ring by 52.30 (11)/49.05 (11), 80.94 (10)/88.36 (10) and 60.58 (7)/83.76 (7)°, respectively. The crystal packing is stabilized by weak C—H⋯N hydrogen bonds.

Ejemplares similares